Actionable news
0
All posts from Actionable news
Actionable news in LRCX: Lam Research Corporation,

UBS Makes Big Biotech and Pharmaceutical Additions to Equity Focus List

If there was ever a time when investors are thrilled to see the calendar change it could be now. With the fourth quarter just starting, many are more than relieved to put the third quarter in the rear-view mirror, as it was the worst since 2011. Like many Wall Street firms we cover, UBS has made some changes to the Equity Focus list for the final three months of 2015.

The UBS Equity Focus list was outperforming the market smartly through July, but it underperformed during the recent massive sell-off. With a pro-cyclical bias, and an energy overweight, the analysts are playing for a long-term payoff that could be outstanding. Most importantly, the portfolio team is not looking back to second guess, but looking forward to economic and market potential.

Three stocks were added and three are removed, and with the UBS team firmly believing that markets are poised to rebound, the portfolio list will benefit.

ALSO READ: 2 Deutsche...


More